Literature DB >> 31249270

Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction.

Giulia Rastrelli1, Giovanni Corona2, Mario Maggi1,3,4.   

Abstract

Low testosterone (T) is frequent in men with chronic illnesses. The clinical features of T deficiency (TD) overlap with those of chronic diseases. The aim of this study is to evaluate the relative contribution of chronic disease score (CDS) and low T to the presence of TD symptoms. A consecutive series of 3862 men (aged 52.1 ± 13.1 years) consulting for sexual dysfunction were studied. Several clinical and biochemical parameters were collected, including the structured interview, ANDROTEST, for the assessment of TD symptoms. Penile color Doppler ultrasound (PCDU) was also performed. Based on the medications taken, the CDS was calculated. For a subset of 1687 men, information on mortality was collected (follow-up of 4.3 ± 2.6 years). Higher CDS was associated with lower free and total T (TT) as well as with higher ANDROTEST score. When introducing CDS and TT in multivariable models adjusted for age, severe erectile dysfunction and impaired morning erections were associated with both CDS (odds ratio and 95% confidence interaval, OR [95% CI] = 1.25 [1.13; 1.37] and 1.38 [1.29; 1.48], respectively) and low TT (OR [95% CI] = 1.11 [1.00; 1.23] and 1.13 [1.06; 1.21], respectively). Similar results were obtained for PCDU parameters. Hypoactive sexual desire was associated with low TT (OR [95% CI] = 1.21 [1.13; 1.30]), whereas it was inversely related with CDS (OR [95% CI] = 0.91 [0.84; 0.97]). When considering mortality for major cardiovascular events, TT <8 nmol l-1, but not CDS, was a significant predictor (hazard ratio [95% CI] = 5.57 [1.51; 20.63]). Chronic illnesses are associated with an overt TD. Both chronic diseases and low T can be involved in determining symptoms present in subjects complaining for sexual dysfunction. This should be considered in the diagnostic workup for TD.

Entities:  

Keywords:  chronic diseases; erectile dysfunction; sexual symptoms; testosterone deficiency

Mesh:

Substances:

Year:  2020        PMID: 31249270      PMCID: PMC7275801          DOI: 10.4103/aja.aja_61_19

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  39 in total

1.  Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men.

Authors:  Laurence Katznelson; Mara W Robinson; Caryn L Coyle; Hang Lee; Christina E Farrell
Journal:  Eur J Endocrinol       Date:  2006-12       Impact factor: 6.664

2.  Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS.

Authors:  Giulia Rastrelli; Terence W O'Neill; Tomas Ahern; György Bártfai; Felipe F Casanueva; Gianni Forti; Brian Keevil; Aleksander Giwercman; Thang S Han; Jolanta Slowikowska-Hilczer; Michael E J Lean; Neil Pendleton; Margus Punab; Leen Antonio; Jos Tournoy; Dirk Vanderschueren; Mario Maggi; Ilpo T Huhtaniemi; Frederick C W Wu
Journal:  Clin Endocrinol (Oxf)       Date:  2018-07-23       Impact factor: 3.478

3.  A chronic disease score from automated pharmacy data.

Authors:  M Von Korff; E H Wagner; K Saunders
Journal:  J Clin Epidemiol       Date:  1992-02       Impact factor: 6.437

Review 4.  Predicting low testosterone in aging men: a systematic review.

Authors:  Adam C Millar; Adrian N C Lau; George Tomlinson; Alan Kraguljac; David L Simel; Allan S Detsky; Lorraine L Lipscombe
Journal:  CMAJ       Date:  2016-06-20       Impact factor: 8.262

5.  A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.).

Authors:  S Crown; A H Crisp
Journal:  Br J Psychiatry       Date:  1966-09       Impact factor: 9.319

Review 6.  Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study.

Authors:  Giovanni Corona; Giulia Rastrelli; Matteo Monami; André Guay; Jaques Buvat; Alessandra Sforza; Gianni Forti; Edoardo Mannucci; Mario Maggi
Journal:  Eur J Endocrinol       Date:  2011-08-18       Impact factor: 6.664

7.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

8.  Late-onset hypogonadism and mortality in aging men.

Authors:  S R Pye; I T Huhtaniemi; J D Finn; D M Lee; T W O'Neill; A Tajar; G Bartfai; S Boonen; F F Casanueva; G Forti; A Giwercman; T S Han; K Kula; M E Lean; N Pendleton; M Punab; M K Rutter; D Vanderschueren; F C W Wu
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

9.  Association between psychiatric symptoms and erectile dysfunction.

Authors:  Giovanni Corona; Valdo Ricca; Elisa Bandini; Edoardo Mannucci; Luisa Petrone; Alessandra D Fisher; Francesco Lotti; Giancarlo Balercia; Carlo Faravelli; Gianni Forti; Mario Maggi
Journal:  J Sex Med       Date:  2007-11-14       Impact factor: 3.802

10.  Natural history, risk factors and clinical features of primary hypogonadism in ageing men: Longitudinal Data from the European Male Ageing Study.

Authors:  Tomás Ahern; Agnieszka Swiecicka; Robert J A H Eendebak; Emma L Carter; Joseph D Finn; Stephen R Pye; Terence W O'Neill; Leen Antonio; Brian Keevil; György Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Giulia Rastrelli; Martin K Rutter; Dirk Vanderschueren; Ilpo T Huhtaniemi; Frederick C W Wu
Journal:  Clin Endocrinol (Oxf)       Date:  2016-08-18       Impact factor: 3.478

View more
  1 in total

Review 1.  The role of testosterone in male sexual function.

Authors:  Giovanni Corona; Mario Maggi
Journal:  Rev Endocr Metab Disord       Date:  2022-08-23       Impact factor: 9.306

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.